Brain Scientific (BRSF) Plans to Enter New Markets While Making EEGs More Accessible
Ease of use, compatibility with third-party EEG amplifiers has created diverse target markets for BRSF’s NeuroCap Recent forecasts show telemedicine industry expected to experience CAGR of 15.1% through 2027 BRSF has potential to disrupt sleep industry, which is forecast to reach $585 billion by 2025 Brain Scientific (OTCQB: BRSF) is offering solutions to the EEG industry’s limitations. The current method of administering an EEG is slow and expensive, plus requires specialized EEG technologists and bulky equipment. This essential procedure is not easily accessible to all, particularly those in rural communities, because of the expense and a neurologist shortage. The NeuroCap(TM)…